Anthropogenic and climate impacts on carbon stocks of grassland ecosystems in Inner Mongolia and adjacent region.

Up to date, most studies reported that degradation is worsened in the grassland ecosystems of Inner Mongolia and adjacent regions as a result of intensified grazing. This seems to be scientific when considering the total forage or total above-ground biomass as a degradation indicator, but it does not hold true in terms of soil organic carbon density (SOCD). In this study, we quantified the changes of grassland ecosystem carbon stock in Inner Mongolia and adjacent regions from the 1980s to 2000s and identified the major drivers influencing these variations, using the National Grassland Resource Inventory and Soil Survey Dataset in 1980s and the Inventory data during 2002 to 2009 covering 624 sampling plots concerned vegetal traits and edaphic properties across the study region. The result indicated that the above-, below-ground and total vegetation biomass declined from the 1980s to 2000s by ∼ 10 %. However, total forage production increased by 6.72 % when considering livestock intake. SOCD remained stable despite a 67 % increase in grazing intensity. A generalized linear model (GLIM) analysis suggested that an increase in grazing intensity from the 1980s to 2000s could only explain 1.04 % of the total biomass change, while changes in precipitation and temperature explained 17.7 % (p < 0.05) of total vegetation biomass (TVB) change. Meanwhile, SOCD change during 1980s - 2000s could be explained 10.08 % by the soil texture (p < 0.05) and <1.6 % by changes in climate and livestock. This implies that the impacts of climate change on grassland biomass are more significant than those of grazing utilization, and SOCD was resistant to both climate change and intensified grazing. Overall, intensified grazing did not result in significant negative impacts on the grassland carbon stocks in the study region during the 1980s and 2000s. The grassland ecosystems possess a mechanism to adjust their root-shoot ratio, enabling them to maintain resilience against grazing utilization.

Discovery of bioactive polycyclic polyprenylated acylphloroglucinols with adamantine/homoadamantane skeletons from Hypericum wilsonii.

In this work, nine previous undescribed polycyclic polyprenylated acylphloroglucinols with adamantine/homoadamantane skeletons, cumilcinols A-I (1-9), along with six known analogues, were isolated and identified from the stems, leaves and flowers of Hypericum wilsonii. Their structures were determined by HRESIMS, NMR spectroscopic analysis, single-crystal X-ray crystallography as well as electronic circular dichroism calculations and comparisons. Compound 2 formed a unique furan ring bearing a rare acetal functionality. In bioassays, hyperacmosin G (13) could significantly inhibit the production of NO in LPS-stimulated RAW264.7 cell (IC50 = 4.350 ± 1.146 µM), and increased expression of related transcription factors at the gene level, inhibit the nuclear translocation of NF-κBp65, and reduce the protein expression of COX-2. Additionally, compound 5 showed significant inhibitory activity on Con A-induced T-lymphocyte proliferation (IC50 = 4.803 ± 3.149 µM), and treatment of 5 could reduce the increased ratio of CD4 and CD8 subpopulations induced by Con A in vitro. Those results indicated 13 possesses potential anti-inflammatory activity, and 5 exhibits a certain degree of immunosuppressive activity.

Discovery of ergosterol derivative from Aspergillus sp. TJ507 that protects against hepatic ischemia/reperfusion injury.

Hepatic ischemia/reperfusion injury is a major cause of hypohepatia after surgical procedures such as hypovolemic shock, transplantation, and so on. In our continuous study of bioactive natural products from fungus, eight ergosterol-type sterides (1-8), including two undescribed compounds, sterolaspers A (1) and B (2), were isolated from Aspergillus sp. TJ507. Structure elucidation was accomplished by extensive spectroscopic analysis and comparison with the reported NMR data as well as X-Ray single crystal diffraction tests. Activity screen of these isolates showed 5α-stigmast-3,6-dione (3) possessing anti-hypoxia injury effects against CoCl2-induced hypoxia damage in hepatocytes. More importantly, compound 3 could improve liver function, alleviate liver damage, and restrain the hepatocellular apoptosis in hepatic ischemia/reperfusion injury murine model. As such, this ergosterol-type steride, 5α-stigmast-3,6-dione (3), might serve as lead structure for the development of novel hepatoprotective agents in the clinical treatment of hepatic ischemia/reperfusion injury.